Antibacterial resistance leadership group: open for business.

Published

Journal Article (Review)

Funded by the National Institute of Allergy and Infectious Diseases, the Antibacterial Resistance Leadership Group (ARLG) is tasked with developing a clinical research agenda and conducting clinical studies to address the growing public health threat of antibacterial resistance. The ARLG has identified 4 high-priority areas of research: infections caused by gram-negative bacteria, infections caused by gram-positive bacteria, antimicrobial stewardship and infection prevention, and diagnostics. The ARLG will be accepting proposals from the scientific community for clinical research that addresses 1 or more of these high-priority areas. These studies should have the potential to transform medical practice and be unlikely to occur without ARLG support. The purpose of this article is to make interested parties aware of clinical research opportunities made available by ARLG and to encourage submission of clinical research proposals that address the problem of antibacterial resistance.

Full Text

Duke Authors

Cited Authors

  • Chambers, HF; Bartlett, JG; Bonomo, RA; Chiou, C; Cosgrove, SE; Cross, HR; Daum, RS; Downing, M; Evans, SR; Knisely, J; Kreiswirth, BN; Lautenbach, E; Mickley, BS; Patel, R; Pettigrew, MM; Rodvold, KA; Spellberg, B; Fowler, VG

Published Date

  • June 2014

Published In

Volume / Issue

  • 58 / 11

Start / End Page

  • 1571 - 1576

PubMed ID

  • 24610430

Pubmed Central ID

  • 24610430

Electronic International Standard Serial Number (EISSN)

  • 1537-6591

Digital Object Identifier (DOI)

  • 10.1093/cid/ciu132

Language

  • eng

Conference Location

  • United States